By Ryan Starkes R&D expenditures in the biotechnology industry have declined for the second straight year as companies narrow their focus to only the most…
A roundtable featuring: Karen King, President, DSM Biologics Nancy Gillett, corp. executive VP and president, Global Preclinical Services, Charles River Sally Waterman Ph.D., COO, PolyTherics…